AgeX Therapeutics, Inc. (AGE)

R&D Expenses

$3.82M

Quarterly · Period ending: · USD

AGE logo

AGE R&D Expenses

Latest reported$3.82M
AGE Quarterly R&D Expenses ($2.39M → $3.82M)
High-resolution chart · PNG

AGE r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
3,816,000
3,199,000
3,401,000
3,651,000
3,152,000
2,951,000
6,007,000
2,415,000
1,594,000
1,106,000
149,000
218,000
160,000
174,000
208,000
162,000
259,000
396,000
376,000
275,000
481,000
324,000
1,186,000
839,000
1,350,000
1,603,000
1,469,000
1,447,000
1,650,000
1,338,000
1,523,000
1,332,000
1,384,000
2,391,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.